Brean Capital analyst Difei Yang weighed in with some insights on Zogenix, Inc. (NASDAQ:ZGNX) ahead of the vote to approve a reverse stock split of outstanding …
Brean Capital analyst Difei Yang weighed in today with her thoughts on Conatus Pharmaceuticals Inc (NASDAQ:CNAT), after the company announces the appointment of Dr. Jean Chan to …
In a research report released Thursday, Brean Capital analyst Difei Yang maintained a Buy rating on Zogenix, Inc. (NASDAQ:ZGNX) with a price target of …
Brean Capital’s healthcare analyst Difei Yang weighed in with her views on Zogenix, Inc. (NASDAQ:ZGNX), after the company released its first-quarter results, posting revenue of …
Brean Capital analyst Difei Yang weighed in today with her views on Horizon Pharma PLC (NASDAQ:HZNP), after the company reported its first-quarter results, posting revenue …
In a research report released April 30, Brean Capital analyst Difei Yang reiterated a Buy rating on Aerie Pharmaceuticals Inc (NASDAQ:AERI) with a $24 price …
Brean Capital analyst Difei Yang was out pounding the table on Zogenix, Inc. (NASDAQ:ZGNX) Wednesday, reiterating a Buy rating and price target of $2.
In a research report published Tuesday, Brean Capital analyst Difei Yang maintained a Buy rating on Horizon Pharma PLC (NASDAQ:HZNP) and raised the price …
In a research report published Friday, Brean Capital analyst Difei Yang maintained a Buy rating on Osiris Therapeutics, Inc. (NASDAQ:OSIR) with a $19.
In a research report released today, Brean Capital analyst Difei Yang maintained a Buy rating on Horizon Pharma PLC (NASDAQ:HZNP) and raised the price target …
